Now Take Deep Breath: MannKind Finds A Partner for Afrezza

There a saying among health-care investors about investing in companies that are developing exciting experimental drugs that goes like this — Buy the approval sell the launch. n other words, ride the share price higher amid excitement over clinical trial results and bullish sales but get out before the stock falls back to earth when [...]